Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Equity Average (2016 - 2026)

Cryo Cell International's Equity Average history spans 16 years, with the latest figure at -$18.5 million for Q1 2026.

  • Quarterly results put Equity Average at -$18.5 million for Q1 2026, down 32.77% from a year ago — trailing twelve months through Feb 2026 was -$18.5 million (down 32.77% YoY), and the annual figure for FY2025 was -$15.9 million, down 31.24%.
  • Equity Average for Q1 2026 was -$18.5 million at Cryo Cell International, down from -$16.7 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $4.3 million in Q2 2022 to a low of -$18.5 million in Q1 2026.
  • The 5-year median for Equity Average is -$10.2 million (2024), against an average of -$7.2 million.
  • The sharpest move saw Equity Average skyrocketed 293.47% in 2022, then crashed 2221.24% in 2024.
  • Year by year, Equity Average stood at -$2.0 million in 2022, then crashed by 182.55% to -$5.5 million in 2023, then tumbled by 106.16% to -$11.4 million in 2024, then plummeted by 46.82% to -$16.7 million in 2025, then fell by 10.67% to -$18.5 million in 2026.
  • According to Business Quant data, Equity Average over the past three periods came in at -$18.5 million, -$16.7 million, and -$15.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.